Insider Catherine Corrigan plans EXPO (NASDAQ: EXPO) stock sale under Rule 144
Filing Impact
Filing Sentiment
Form Type
144
Rhea-AI Filing Summary
Exponent Inc. insider Catherine Corrigan has filed a Form 144 notice to sell shares of EXPO common stock. The filing covers a planned sale of 3,920 common shares through Morgan Stanley Smith Barney LLC on or about 02/17/2026, with an aggregate market value of $261,816.80. The shares were acquired the same day by exercising stock options for cash.
The notice also reports prior Rule 10b5-1 plan sales over the past three months. These include 1,663 common shares sold on 01/15/2026 for gross proceeds of $120,593.78 and 3,225 common shares sold on 12/15/2025 for $240,171.23. Shares outstanding were 49,887,226 at the time referenced, providing context for the size of these trades.
Positive
- None.
Negative
- None.
FAQ
What does the EXPO Form 144 filing by Catherine Corrigan disclose?
The filing discloses a planned sale of Exponent (EXPO) common stock by insider Catherine Corrigan. It details shares to be sold, market value, acquisition via option exercise, and recent 10b5-1 plan sales over the prior three months.
What recent EXPO stock sales under Rule 10b5-1 are reported?
The filing lists two recent 10b5-1 plan sales for Catherine Corrigan: 1,663 common shares sold on 01/15/2026 for $120,593.78 and 3,225 shares sold on 12/15/2025 for $240,171.23, showing prior trading activity.